Search results for "Risk factor."

showing 10 items of 4316 documents

Short-Term Prognosis of Juvenile Myocardial Infarction

2016

In our early research regarding the hemorheological pattern in patients with acute myocardial infarction (AMI) with a mean age of 61.45 + 10.99 years, we showed that the major hemorheological parameters were almost normalized 2 weeks after the acute event. In the last decade, we focused on hemorheological parameters in juvenile myocardial infarction (JMI), defined as AMI in patients aged 45 years, in the ‘‘Sicilian study on juvenile myocardial infarction’’. Juvenile myocardial infarction is responsible for 2% to 10% of all cases with AMI in different surveys. Juvenile myocardial infarction presents a typical pattern of risk factors and shows clinical, angiographic, and prognostic characteri…

AdultMalemedicine.medical_specialtyTime FactorsIschemic heart diseaseBlood viscosity030204 cardiovascular system & hematologyBlood rheology030218 nuclear medicine & medical imagingAnginaCoronary artery diseasePlasma03 medical and health sciences0302 clinical medicineRisk FactorsDiabetes mellitusInternal medicinemedicineHumansMyocardial infarctionAge of OnsetRisk factorNon-ST Elevated Myocardial InfarctionBlood rheology; Myocardial infarction; Ischemic heart diseaseMedicine (all); Cardiology and Cardiovascular Medicinebusiness.industryMedicine (all)HemodynamicsBlood ViscosityPrognosismedicine.diseaseMyocardial infarctionHeart failureCoronary vesselDisease ProgressionCardiologyST Elevation Myocardial InfarctionFemaleCardiology and Cardiovascular MedicinebusinessAngiology
researchProduct

Prognostic Value of a Comprehensive Cardiac Magnetic Resonance Assessment Soon After a First ST-Segment Elevation Myocardial Infarction

2009

ObjectivesTo evaluate the prognostic value of a comprehensive cardiac magnetic resonance (CMR) assessment soon after a first ST-segment elevation myocardial infarction (STEMI).BackgroundCMR allows for a simultaneous assessment of wall motion abnormalities (WMA), WMA with low-dose dobutamine (WMA-dobutamine), microvascular obstruction, and transmural necrosis. This approach has been proven to be useful to predict late systolic recovery soon after STEMI. Its prognostic value and the relative prognostic weight of these indexes are not well-defined.MethodsWe studied 214 consecutive patients with a first STEMI treated with thrombolytic therapy or primary angioplasty discharged from hospital. In …

AdultMalemedicine.medical_specialtyTime FactorsMagnetic Resonance Imaging CineInfarctionKaplan-Meier EstimateRisk Assessmentcardiac magnetic resonanceNecrosisPredictive Value of TestsRecurrenceRisk FactorsDobutamineInternal medicinemedicineHumansThrombolytic TherapyRadiology Nuclear Medicine and imagingcardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronaryAgedProportional Hazards ModelsHeart Failurebusiness.industryMyocardiumAdrenergic beta-AgonistsMiddle Agedmedicine.diseaseCoronary VesselsMyocardial ContractionTreatment Outcomemyocardial infarctionRadiology Nuclear Medicine and imagingHeart failureMicrovesselscardiovascular systemCardiologyMyocardial infarction complicationsFemaleDobutamineprognosisMyocardial infarction diagnosisCardiology and Cardiovascular MedicinebusinessTIMIMacemedicine.drugJACC: Cardiovascular Imaging
researchProduct

Lung Preservation With Perfadex or Celsior in Clinical Transplantation: A Retrospective Single-Center Analysis of Outcomes.

2015

BACKGROUND Despite improvement of lung preservation by the introduction of low-potassium dextran (LPD) solution, ischemia-reperfusion injury remains a major contributor to early post-lung transplant graft dysfunction and mortality. After favorable experimental data, Celsior solution was used in our clinical lung transplant program. Data were compared with our historic LPD cohort. METHODS Between January 2002 and January 2005, 209 consecutive lung transplantations were performed with LPD. These were compared to 208 transplants between February 2005 and September 2007 with Celsior. Endpoints included posttransplant PaO2/FiO2 ratio at different timepoints after intensive care unit (ICU) admiss…

AdultMalemedicine.medical_specialtyTime FactorsOrgan Preservation SolutionsBronchiolitis obliteransKaplan-Meier EstimateSingle CenterDisaccharidesDisease-Free Survivallaw.inventionElectrolytesGlutamateslawRisk FactorsGermanymedicineHumansHistidineMannitolCitratesProportional Hazards ModelsRetrospective StudiesTransplantationLungProportional hazards modelbusiness.industryRetrospective cohort studyOrgan PreservationLength of StayMiddle Agedmedicine.diseaseIntensive care unitGlutathioneRespiration ArtificialSurgeryTransplantationIntensive Care Unitsmedicine.anatomical_structureTreatment OutcomeCohortBronchiolitisFemalePrimary Graft DysfunctionbusinessLung TransplantationTransplantation
researchProduct

Long-term radiation exposure in patients undergoing EVAR: Reflecting clinical day-to-day practice to assess realistic radiation burden.

2018

Endovascular repair of aortic aneurysms (EVAR) has become an established treatment option currently applied in an increasing numbers of patients with aortic aneurysms. Advantages include reduced surgical trauma, procedural time, intensive care unit and hospital lengths of stay, blood loss as well as morbidity and mortality.The optimal imaging modalities in EVAR follow-up as well as the appropriate intervals between these follow-ups remain subject of controversial discussion. Objective of this study was the evaluation of the realistic radiation exposure and risk estimate postop EVAR treatment.Of the follow-ups required according to the surveillance schedule during the first year post-EVAR, o…

AdultMalemedicine.medical_specialtyTime FactorsPhysiology030204 cardiovascular system & hematology030218 nuclear medicine & medical imaginglaw.invention03 medical and health sciencesAortic aneurysm0302 clinical medicinelawRisk FactorsPhysiology (medical)medicineHumansIn patientAgedAged 80 and overbusiness.industryTreatment optionsHematologyMiddle AgedRadiation Exposuremedicine.diseaseIntensive care unitTerm (time)Radiation exposureRisk EstimateTreatment OutcomeEmergency medicineFemaleDay to dayCardiology and Cardiovascular MedicinebusinessAortic Aneurysm AbdominalClinical hemorheology and microcirculation
researchProduct

[Inferior vena cava malformations and deep venous thrombosis].

2006

We carried out a prospective study of 116 patients under 50 years of age who had deep venous thrombosis of the lower extremities to determine whether the presence of congenital anomaly of the inferior vena cava (IVC) was a risk factor for the disease. All patients were investigated by Doppler echography. Some 37 patients who had iliac vein occlusion also underwent phlebography. In 10 patients in whom the IVC was difficult to image, magnetic resonance angiography or computerized axial tomography was carried out. In all patients, studies of antithrombin, protein C and protein S deficiency, factor V Leiden, prothrombin G20210A, antiphospholipid antibodies, and acquired risk factors were also p…

AdultMalemedicine.medical_specialtyTime FactorsPopliteal VeinFemoral veinVena Cava InferiorIliac VeinInferior vena cavaRecurrenceRisk FactorsmedicineFactor V LeidenConfidence IntervalsHumansProtein S deficiencyProspective StudiesVenous ThrombosisLegbusiness.industryAnticoagulantsUltrasonography DopplerGeneral MedicinePhlebographyFemoral VeinMiddle Agedmedicine.diseaseThrombosisVein occlusionSurgeryVenous thrombosisTreatment Outcomemedicine.veincardiovascular systemProthrombin G20210AFemaleRadiologybusinessTomography X-Ray ComputedMagnetic Resonance AngiographyFollow-Up StudiesRevista espanola de cardiologia
researchProduct

Lipoprotein(a) is not associated with venous thromboembolism risk.

2020

Objectives. Evidence from case-control studies as well as meta-analyses of these study designs suggest elevated lipoprotein(a) [Lp(a)] to be associated with an increased risk of venous thromboembolism (VTE). Prospective evidence on the association is limited, uncertain, and could be attributed to regression dilution bias. We aimed to assess the prospective association of Lp(a) with risk of VTE and correct for regression dilution. Design. We related plasma Lp(a) concentrations to the incidence of VTE in 2,180 men of the Kuopio Ischemic Heart Disease cohort study. Hazard ratios (HRs) (95% confidence intervals [CI]) were assessed and repeat measurements of Lp(a) at 4 and 11 years from baseline…

AdultMalemedicine.medical_specialtyTime FactorsPopulationRegression dilutionvenous thromboembolism030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicinecohort studyHumans030212 general & internal medicineregression dilutionProspective StudiesRisk factoreducationFinlandeducation.field_of_studybiologybusiness.industryIncidenceHazard ratioConfoundingLipoprotein(a)Venous ThromboembolismMiddle AgedPrognosisConfidence intervalrisk factorbiology.proteinCardiology and Cardiovascular MedicinebusinessBiomarkersCohort studyLipoprotein(a)Scandinavian cardiovascular journal : SCJ
researchProduct

Oxidative stress in young subjects with acute myocardial infarction: evaluation at the initial stage and after 12 months.

2007

In 105 subjects (97 men and 8 women) aged <46 years (mean age 39.6 ± 5.5 years), with recent acute myocardial infarction (T1), thiobarbituric acid reactive substances and total antioxidant status were determined; NO production was evaluated by measuring the nitrite and nitrate (NOx) concentration. The patients with acute myocardial infarction were subdivided according to the main risk factors, number of risk factors, and extent of coronary lesions. The evaluation was repeated after 12 months (T2). In these subjects, thiobarbituric acid reactive substances and NOx were significantly increased and total antioxidant status was significantly decreased at T1. In single risk factor, only NO m…

AdultMalemedicine.medical_specialtyTime FactorsThiobarbituric acidMyocardial Infarctionmedicine.disease_causeNitric OxideGastroenterologyNitric oxideLipid peroxidationchemistry.chemical_compoundRisk FactorsInternal medicineMedicineHumansMyocardial infarctionStage (cooking)Risk factorNitritebusiness.industryacute myocardial infarction in young peopleHematologyGeneral Medicineoxidative statuMiddle Agedmedicine.diseaseSurgeryOxidative StresschemistryAcute DiseaseFemaleLipid PeroxidationbusinessOxidative stressClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
researchProduct

Total polyphenol intake, polyphenol subtypes and incidence of cardiovascular disease: The SUN cohort study.

2018

Abstract Background and aims Polyphenol-rich diets have been associated with reduced risk of cardiovascular disease (CVD). However, few prospective epidemiological studies have examined the relationship between classes of ingested polyphenols and risk of CVD. Our aim was to evaluate the association between polyphenol intake and risk of major cardiovascular events in a prospective Spanish cohort. Methods and results We included 17,065 university graduates (60.7% women, mean age: 37.2 years, age range: 20–89) followed-up for a mean of 10.1 years. Polyphenol intake was assessed at baseline using a validated semi-quantitative 136-item food frequency questionnaire and matching food consumption d…

AdultMalemedicine.medical_specialtyTime FactorsUniversitiesEndocrinology Diabetes and MetabolismMedicine (miscellaneous)030209 endocrinology & metabolism030204 cardiovascular system & hematologyDiet Surveys03 medical and health sciencesYoung Adult0302 clinical medicineRisk FactorsInternal medicineEpidemiologymedicineHumansProspective StudiesProspective cohort studyStudentsAgedAged 80 and overNutrition and Dieteticsbusiness.industryProportional hazards modelIncidence (epidemiology)IncidenceHazard ratioConfoundingfood and beveragesPolyphenolsMiddle AgedProtective FactorsDietCardiovascular DiseasesSpainCohortFemaleCardiology and Cardiovascular MedicinebusinessCohort studyNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

Lower plasma testosterone levels enhance the predictive value of endothelial dysfunction for future cardiovascular events: A 5-year prospective study.

2016

LETTER TO EDITOR

AdultMalemedicine.medical_specialtyTime FactorsUrology030204 cardiovascular system & hematologySettore MED/24 - UrologiaCardiovascular events.Cohort Studies03 medical and health sciences0302 clinical medicinePredictive Value of TestsRisk FactorsInternal medicinemedicineHumansTestosterone030212 general & internal medicineEndothelial dysfunctionProspective StudiesEndothelial dysfunctionProspective cohort studyAgedAged 80 and overbusiness.industryMedicine (all)Testosterone (patch)Middle Agedmedicine.diseasePredictive valueSettore MED/11 - Malattie Dell'Apparato CardiovascolareDeathEndocrinologyCardiovascular DiseasesEndothelium VascularbusinessCardiology and Cardiovascular MedicineBiomarkersFollow-Up StudiesForecastingInternational journal of cardiology
researchProduct

Dose-Adjusted Thrombosis Prophylaxis in Trauma Surgery According to Levels of D-Dimer

2000

In 234 trauma surgery patients, thrombosis prophylaxis with Nadroparin-Calcium low-molecular-weight heparin (LMWH) was adjusted according to levels of D-Dimer. Basic prophylaxis was 2,850 IU per day. If D-Dimer concentrations rose above 2 mg/L after the fourth postoperative (p.o.) day, LMWH was administered twice a day. Color Doppler ultrasound was performed between the fifth and seventh p.o. days. Patients were divided into a high-risk (group 1: hip, femur, or knee replacement surgery, n=102) and a moderate-risk group (group 2: other surgery of the knee, tibia, fibula, or foot, n=132). Group 1 showed significantly higher D-Dimer levels than group 2 (p0.001). Measurement of D-Dimer on days …

AdultMalemedicine.medical_specialtyTime Factorsmedicine.drug_classmedicine.medical_treatmentDeep veinAntithrombin IIIKnee replacementLow molecular weight heparinSensitivity and SpecificityFibrin Fibrinogen Degradation ProductsFractures BoneRisk FactorsAntifibrinolytic agentD-dimerHumansMedicineAgedAged 80 and overVenous Thrombosisbusiness.industryAnticoagulantNadroparinHematologyMiddle Agedmedicine.diseaseAntifibrinolytic AgentsSurgeryVenous thrombosismedicine.anatomical_structureAnesthesiaWounds and InjuriesFemalebusinessTrauma surgeryBiomarkersLeg InjuriesPeptide HydrolasesThrombosis Research
researchProduct